Generix Announces New AI-Powered Resource Management System (RMS) to Intelligently Optimize All Warehouse Resources
Article content
Article content
PARIS — Generix, a global business software company offering an expansive portfolio of SaaS solutions for supply chain, finance, commerce, and B2B integration, today announces the launch of Generix Resource Management Systems (RMS), a new AI-powered application that optimizes all warehouse resources through intelligent forecasting, planning, and analytics – all in a single environment.
Article content
As many warehouse management teams struggle to keep pace with supply chain disruptions with error-prone, disparate manual tools, Generix RMS provides the precise forecasting and planning capabilities needed to control labor costs, maximize resource utilization, and improve visibility into capacity.
Article content
'In a world dominated by unpredictability, we know that the stakes are too high, and supply chains are too complex to simply rely on spreadsheets for planning and managing all warehouse resources,' stated Si-Mohamed Saïd, Chief Product & Marketing Officer, Generix. 'The new Generix RMS has the unique ability to bring together intelligent forecasting and planning to any warehouse. With RMS powered by AI, warehouse managers can now go from 'what if' to 'let's go' faster than ever.'
Article content
The new SaaS application can easily integrate into existing warehouse management systems (WMS), turning warehouse and HR data into more accurate and actionable plans.
Article content
Generix RMS helps companies get the most value from all warehouse resources:
Article content
Delivering intelligent forecasting and planning by applying embedded AI to all WMS and HR data – allowing companies to deliver intelligent forecasts, plans that assess potential constraints, and help predict workloads – all in a single experience.
Optimally manage every job, task, and resource. Generix RMS works across locations and integrates with any WMS – allowing for more efficient management of all resources. This includes everything from people to equipment and machinery, to maximizing productivity, utilization, and employee engagement.
Turn instant insight to action by shifting quickly from planning to performance with built-in analytics – allowing for continuous resource utilization adjustments and on-the-fly reallocations.
Article content
Generix is a global SaaS company helping connect businesses together to turn each digital connection into digital value. It offers a leading portfolio of cloud solutions and services powered by AI to drive with confidence the most mission-critical digital business processes in supply chain, finance and commerce. It also provides end-to-end B2B integration and collaboration solutions so companies can fully operate across digital business networks. Nearly 900 Generix talents are dedicated to best serve over 5,000 customers across more than 60 countries. The company helps to process more than 17 billion messages, prepare more 600 million pallets, manage over 500 million invoices and more than 1 million transport operations per year. Generix believes in the immense growth potential of the networked economy in a sustainable world. More info: www.generixgroup.com
Article content
Article content
Article content
Article content
Article content
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
11-08-2025
- Cision Canada
NicheRMS365 selected as RMS of choice for the Toronto Police Service
TORONTO, Aug. 11, 2025 /CNW/ -- Niche Technology Inc. (Niche) is pleased to announce the Toronto Police Service (TPS), Canada's largest municipal police agency and the fourth largest municipal police agency in North America, has chosen NicheRMS365 as its next generation Records Management System (RMS). "We're extremely proud that TPS chose a made-in-Canada solution," says Fiona Scrimshaw, Niche Technology's Vice-President, Project Management, North America & Australasia. "From our early beginnings in Winnipeg in 1999, the unmatched configurability and advanced features of NicheRMS365 has made it the world's leading RMS solution with more super-major police agencies than our top 8 competitors combined." By selecting NicheRMS365, following a competitive procurement process, to enhance its operational police management capabilities, TPS joins an esteemed roster of large-scale police agencies in North America and around the world that have embraced Niche's out-of-the-box cutting-edge platform to deliver the latest technological innovations used to battle crime and enhance community safety. "This modern and intuitive RMS will transform how TPS manages operational records and data. It streamlines the flow of information from cruisers to courts, eliminates manual transcription and allows officers to create links for suspects, vehicles, addresses, and digitizes property collection, all on officer's mobile devices," said Colin Stairs, Chief Transformation Officer at the TPS. "This enhanced approach to data, connecting criminal activity and offenders, will streamline the prosecution process, and enhance the overall safety and well-being of the communities we serve." Selecting NicheRMS365 will provide TPS officers with Niche's proprietary Mobile First advantage – full access to the key RMS features through their mobile phones. "Our frontline officers will have real-time information literally in their hands so they can help the community members they're assisting and solve crimes," said Stairs who says Niche's approach to transforming policing through the deployment of technology made it a good fit for TPS. "Implementing technology that drives effectiveness, efficiency and accountability, is how we modernize our service and the information management tools we select need to scale with our size and our ambitions. NicheRMS365 will give us the flexibility and configurability we need to continually drive agility and innovation at TPS." Niche Technology Inc. looks forward to working closely with Stairs and his team to ensure a transition to NicheRMS365 that delivers in all key areas of the TPS to improve community safety and better serve the citizens of Toronto. NicheRMS365's track record as an evergreen RMS with an almost infinite number of configurable features has led to its widespread adoption by police agencies whose collective staffing approximate a quarter million. It is also the most widely used RMS in Canada, currently licensed coast to coast by 75% of the Nation's police officers. NicheRMS365 is the world's leading RMS platform used by large police agencies in North America, Australia, and the United Kingdom. About the Toronto Police Service Founded in 1834, the Toronto Police Service is the largest municipal police service in Canada, and the fourth largest in North America after New York, Los Angeles and Chicago. It is also the second oldest continuously operating municipal police force in the world. TPS is older than the New York City Police Department (1845), and Boston Police Department (1839). There are 5,300 sworn officers within the TPS and 2,500 civilian personnel. TPS has worked diligently to be more transparent and accountable to the public by better defining the services it provides and by re-aligning its performance metrics to a service delivery model. Th service is focused on three priorities: improve trust in and within the Service, accelerate police reform and professionalization and support safer communities About Niche Technology and NicheRMS365 Niche Technology is the world's leading RMS provider with customers in both hemispheres on three continents. At Niche we focus on the information demands of frontline officers when seconds count. The responsive NicheRMS365 UI provides a consistent, intuitive user experience on phone, tablet, laptop and desktop devices, so agencies can simply train once and use anywhere – on any device. Our customers have rewarded Niche Technology's innovation by making us the leading RMS provider worldwide, with more super-major police agencies using NicheRMS365 than our top 8 competitors combined. It's the most highly configurable, capable and respected RMS platform in the world.
Cision Canada
04-08-2025
- Cision Canada
SYSPRO Deepens Warehouse Management Capabilities with Acquisition of DATASCOPE
Third strategic acquisition in 12 months advances SYSPRO's goal to deliver fully integrated, end-to-end digital manufacturing ERP and WMS solutions for global manufacturers and distributors TUSTIN, Calif., Aug. 4, 2025 /CNW/ -- SYSPRO, a global software provider for the manufacturing and distribution industries, today announced the acquisition of DATASCOPE, a U.S.-based Warehouse Management System (WMS) provider with over two decades of deep functional and technical alignment within the SYSPRO platform. This marks SYSPRO's third strategic acquisition in 12 months, following the recent purchases of NexSys and riteSOFT. DATASCOPE brings a WMS platform already deeply embedded in the SYSPRO ecosystem, delivering immediate value to customers through seamless alignment and operational continuity. With a strong global customer base and proven domain expertise, DATASCOPE expands SYSPRO's capabilities in warehouse and inventory management, enabling a more unified and scalable ERP experience tailored to the needs of modern manufacturers and distributors. The acquisition enhances SYSPRO's ability to deliver a fully integrated ERP and WMS platform. Customers will benefit from greater inventory visibility, supply chain control, and operational efficiency, with minimal disruption and maximum speed-to-value thanks to DATASCOPE's native SYSPRO alignment. Partners can now offer more comprehensive warehouse management solutions with confidence, helping to differentiate their offerings and enter new market segments with a pre-integrated WMS solution. DATASCOPE represents the next step in SYSPRO's strategic growth plan under Advent's ownership, which balances expanding functional depth with operational scale, while preserving SYSPRO's core focus on manufacturing and distribution. The DATASCOPE team will join SYSPRO, bringing valuable expertise and accelerating the shared mission to support manufacturers and distributors worldwide with industry-specific, out-of-the-box solutions. "DATASCOPE has been a long-standing strategic partner, with a solution built to complement and enhance the SYSPRO ERP experience," said Jaco Maritz, CEO of SYSPRO. "This acquisition strengthens our ability to offer an end-to-end, purpose-built digital manufacturing experience that simplifies warehouse and supply chain operations without added complexity." "SYSPRO has always been one of our most important strategic partners," said Anton Jurgens, President and Founder, DATASCOPE. "Our entire solution was built with SYSPRO at its core. As part of SYSPRO, we're now positioned to scale our impact, innovate faster, and better serve our customers on a global level." The transaction remains subject to customary closing conditions, including regulatory approvals and legal proceedings. Financial terms were not disclosed. About DATASCOPE: DATASCOPE is a U.S.-based software company specializing in Warehouse Management Systems for manufacturing and distribution businesses. With over 23 years of experience and a solution built specifically for SYSPRO ERP, DATASCOPE helps customers improve inventory accuracy, streamline operations, and gain end-to-end supply chain visibility. About SYSPRO SYSPRO is a leading, global software provider specializing in key manufacturing and distribution industries. For over 40 years, SYSPRO's team of specialists has continued to address unique industry needs and enable customers to easily adapt and grow. The solution is scalable and can be deployed in the cloud, on-premise, or both, and accessed via the web on any device to provide customers with choice and flexibility. SYSPRO remains focused on the success of partners and customers. Our evolving solutions are aligned with industry trends to leverage emerging technology that will enable partners and customers in securing a digital future. With more than 16,000 customers in over 60 countries across six continents – SYSPRO offers guidance and support every step of the way as a trusted digitalization partner.
Cision Canada
10-06-2025
- Cision Canada
Curadev Expands Strategic Collaboration for CRD3874-SI Through MSK Therapeutics Accelerator Program
BOSTON, June 10, 2025 /CNW/ -- Curadev Pharma, Inc., a clinical-stage biotechnology company developing novel immuno-oncology therapeutics, and Memorial Sloan Kettering Cancer Center (MSK), a world-leading cancer research and treatment institution, are expanding their collaboration through the MSK Therapeutics Accelerator program to advance the development of Curadev's small-molecule allosteric Stimulator of Interferon Genes (STING) agonist, CRD3874-SI, to be delivered systemically to patients with advanced/metastatic cancer. The collaboration builds on the ongoing Phase 1a/b dose escalation and expansion clinical trial (NCT06021626) currently underway at MSK for sarcoma and Merkel cell carcinoma patients, and aims to explore the potential of CRD3874-SI in treating additional types of cancer. Through the MSK Therapeutics Accelerator program, MSK will provide Curadev with expertise and institutional resources, including medical, clinical, and regulatory advice, to further the development of CRD3874-SI. This expanded collaboration marks a significant milestone in translating promising STING pathway research into broader clinical application and will be overseen by William Tap, MD, Chief of the Sarcoma Medical Oncology Service at MSK, and Ciara Kelly, MBBCh BAO, Interim Clinical Director of MSK's Sarcoma Oncology Service. Dr. William Tap said, "MSK and its Division of Solid Tumors are excited to co-develop CRD3874-SI, a novel first-in-class allosteric STING agonist, with Curadev. CRD3874-SI has demonstrated an encouraging safety and efficacy profile in a first-in-human study at MSK. CRD3874-SI is moving forward into multiple solid-tumor expansion cohorts, guided by disease specific experts and the support and structure of the MSK Accelerator Program, which is designed to enhance and expedite the development of novel compounds across malignancies. CRD3874-SI has the potential to offer patients a new treatment option with continued innovation and exploration of the benefits of immunotherapy in cancer care." Dr. Arjun Surya, Co-founder and CEO of Curadev, added, "We are encouraged by the early readouts with CRD3874-SI systemic monotherapy from our ongoing clinical trial in patients with treatment refractory cancers at MSK and are honored by the opportunity to deepen our collaboration through the MSK Therapeutics Accelerator program. The research and development collaboration between oncologists at MSK and the inventors of CRD3874-SI at Curadev could become a role model for advancing bench to bedside medicines. MSK's historic leadership position in the development of cancer immunotherapy and the exemplary dedication of the oncologists we work with is inspiring and make it an ideal partner in Curadev's effort to investigate the therapeutic potential of its systemically administered allosteric STING agonist in patients with advanced/metastatic cancer." About Curadev Curadev is a clinical-stage biotechnology company dedicated to discovering and developing novel small-molecule therapeutics for treating intractable diseases. Curadev has built an impressive portfolio of discovery research programs using a target-centric approach, innovative screening schemes, and traditional wet-lab chemistry and pharmacology, resulting in patent-protected drug candidates that modulate next-generation drug targets. Curadev Pharma, Inc., the US-based clinical development subsidiary founded in 2021, is currently leading the Phase1/2 trials of STING agonist assets under a US FDA-approved IND application. For more information, visit MSK's Therapeutics Accelerator program is a strategic partnership program between MSK and biotechnology companies to advance novel cancer therapeutics through all stages of drug development. The program brings together innovative healthcare companies with MSK's community of clinical and scientific experts to establish groundbreaking collaborations that can have a tangible impact on the treatment or management of cancer.
